[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BioStocks Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::112872946.png) Bio Stocks™ [@BioStocks](/creator/twitter/BioStocks) on x 68.4K followers
Created: 2025-07-16 23:06:41 UTC

$SRPT Q2 total net product revenue: $513M 

ELEVIDYS net product revenue: $282M 

RNA-based PMOs net product revenue: $231M 

Cash, cash equivalents: $850M 

Expects to submit the BLA for SRP-9003 for LGMD type 2E/R4 in 2H'25


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945621138366705946/c:line.svg)

**Related Topics**
[$850m](/topic/$850m)
[$231m](/topic/$231m)
[$282m](/topic/$282m)
[$513m](/topic/$513m)
[$srpt](/topic/$srpt)
[stocks](/topic/stocks)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/BioStocks/status/1945621138366705946)